Repurposing of drugs as STAT3 inhibitors for cancer therapy
Author:
Funder
Cancer Council Victoria
Publisher
Elsevier BV
Subject
Cancer Research
Reference174 articles.
1. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat. Rev. Drug Discov.,2018
2. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials;Rothwell;Lancet,2011
3. A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer;Brandao;Breast Cancer Res.,2013
4. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study;Dowling;Breast Cancer Res.,2015
5. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy;Chauhan;Proc. Natl. Acad. Sci. U. S. A.,2019
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting the STAT3 pathway with STAT3 degraders;Trends in Pharmacological Sciences;2024-09
2. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09
3. Two Keggin-type Germanotungstates: Synthesis, characterization, and antitumor mechanism of mitochondrial apoptosis;Journal of Molecular Structure;2024-08
4. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08
5. CXCR4 promotes migration, invasion, and epithelial–mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway;Journal of Cancer Research and Therapeutics;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3